AR100618A1 - Procedimiento de preparación de albúmina humana con nivel de oxígeno disuelto reducido - Google Patents
Procedimiento de preparación de albúmina humana con nivel de oxígeno disuelto reducidoInfo
- Publication number
- AR100618A1 AR100618A1 ARP150101653A ARP150101653A AR100618A1 AR 100618 A1 AR100618 A1 AR 100618A1 AR P150101653 A ARP150101653 A AR P150101653A AR P150101653 A ARP150101653 A AR P150101653A AR 100618 A1 AR100618 A1 AR 100618A1
- Authority
- AR
- Argentina
- Prior art keywords
- dissolved oxygen
- human albumin
- albumin
- oxygen level
- preparation procedure
- Prior art date
Links
- 102000008100 Human Serum Albumin Human genes 0.000 title abstract 4
- 108091006905 Human Serum Albumin Proteins 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 title abstract 3
- 229910052760 oxygen Inorganic materials 0.000 title abstract 3
- 239000001301 oxygen Substances 0.000 title abstract 3
- 102000009027 Albumins Human genes 0.000 abstract 3
- 108010088751 Albumins Proteins 0.000 abstract 3
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/765—Serum albumin, e.g. HSA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201430824A ES2524516B1 (es) | 2014-05-29 | 2014-05-29 | Procedimiento de preparación de albúmina humana con nivel de oxígeno disuelto reducido |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR100618A1 true AR100618A1 (es) | 2016-10-19 |
Family
ID=52003454
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP150101653A AR100618A1 (es) | 2014-05-29 | 2015-05-27 | Procedimiento de preparación de albúmina humana con nivel de oxígeno disuelto reducido |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US10350274B2 (OSRAM) |
| EP (1) | EP2952203B9 (OSRAM) |
| JP (3) | JP2015224251A (OSRAM) |
| KR (1) | KR101960729B1 (OSRAM) |
| CN (1) | CN105315362B (OSRAM) |
| AR (1) | AR100618A1 (OSRAM) |
| AU (1) | AU2015202413B2 (OSRAM) |
| BR (1) | BR102015012091A8 (OSRAM) |
| CA (1) | CA2890642C (OSRAM) |
| CL (1) | CL2015001446A1 (OSRAM) |
| ES (2) | ES2524516B1 (OSRAM) |
| HU (1) | HUE031823T2 (OSRAM) |
| IL (1) | IL238898B (OSRAM) |
| MX (1) | MX362869B (OSRAM) |
| MY (1) | MY171771A (OSRAM) |
| NZ (1) | NZ708537A (OSRAM) |
| PL (1) | PL2952203T3 (OSRAM) |
| PT (1) | PT2952203T (OSRAM) |
| RU (1) | RU2657578C2 (OSRAM) |
| SG (1) | SG10201504137PA (OSRAM) |
| TW (1) | TWI607018B (OSRAM) |
| ZA (1) | ZA201503539B (OSRAM) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2524516B1 (es) * | 2014-05-29 | 2015-03-31 | Grifols Worldwide Operations Limited | Procedimiento de preparación de albúmina humana con nivel de oxígeno disuelto reducido |
| ES2975517T3 (es) | 2016-04-28 | 2024-07-08 | Alkahest Inc | Fracciones de plasma como terapia para el cáncer de timo |
| SG11201901273TA (en) | 2016-08-18 | 2019-03-28 | Alkahest Inc | Blood plasma fractions as a treatment for aging-associated cognitive disorders |
| CN117899111A (zh) | 2017-04-26 | 2024-04-19 | 万能溶剂有限公司 | 用血浆和血浆制品治疗认知障碍和运动障碍的给药方案 |
| KR20210024196A (ko) | 2018-07-20 | 2021-03-04 | 알카헤스트 인코포레이티드 | 혈장 및 혈장 산물로 인지 및 운동 장애를 치료하기 위한 투여 요법 |
| UA128648C2 (uk) | 2018-10-26 | 2024-09-18 | Алкахест, Інк. | Застосування плазми крові та фракцій плазми для пом'якшення болю, поліпшення загоювання ран та післяопераційного відновлення |
| CN109627322A (zh) * | 2019-01-07 | 2019-04-16 | 中国科学院过程工程研究所 | 一种从Cohn组分Ⅴ上清中分离纯化人血清白蛋白的方法 |
| CA3151943A1 (en) | 2019-11-04 | 2021-05-14 | Viktoria Kheifets | Blood plasma fractions for use in muscle regeneration |
| EP4061384A4 (en) | 2019-11-20 | 2023-11-01 | Alkahest, Inc. | BLOOD PLASMA FRACTIONS FOR USE IN LIVER REGENERATION |
| JP2026511640A (ja) | 2023-03-29 | 2026-04-14 | グリフォルス・ワールドワイド・オペレーションズ・リミテッド | ＦｃεＲＩβ自己抗体のレベルが低減された血漿製剤の組成物および調製方法 |
| CN118166053B (zh) * | 2024-03-15 | 2025-02-07 | 通化安睿特生物制药股份有限公司 | 一种制备低o-糖基化水平的重组人白蛋白的方法 |
| WO2025230830A1 (en) | 2024-04-29 | 2025-11-06 | Alkahest, Inc. | Compositions of blood plasma fractions and their use in treatment of spinal muscular atrophy (sma) |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4094965A (en) * | 1977-04-01 | 1978-06-13 | New England Nuclear Corporation | Diagnostic agents containing albumin and method for making same |
| SE9301581D0 (sv) * | 1993-05-07 | 1993-05-07 | Kabi Pharmacia Ab | Protein formulation |
| JPH07126182A (ja) * | 1993-10-27 | 1995-05-16 | Green Cross Corp:The | 組換えヒト血清アルブミン製剤の滅菌方法 |
| SE9402119D0 (sv) * | 1994-06-16 | 1994-06-16 | Pharmacia Ab | Solution |
| US5766582A (en) * | 1994-10-11 | 1998-06-16 | Schering Corporation | Stable, aqueous alfa interferon solution formulations |
| JP4254117B2 (ja) * | 2001-03-27 | 2009-04-15 | ニプロ株式会社 | アルブミン溶液収容プラスチック容器 |
| DE60234142D1 (de) * | 2001-03-27 | 2009-12-10 | Nipro Corp | Albuminlösung enthaltender Kunststoffbehälter |
| JP4225416B2 (ja) * | 2001-06-29 | 2009-02-18 | 旭化成ファーマ株式会社 | タンパク質製剤の安定性を改善する方法 |
| US7252799B2 (en) * | 2001-08-31 | 2007-08-07 | Clearant, Inc. | Methods for sterilizing preparations containing albumin |
| ATE342904T1 (de) * | 2003-08-28 | 2006-11-15 | Nipro Corp | Künstlicher sauerstoffträger und herstellungsverfahren dafür |
| RS52459B (sr) * | 2006-02-07 | 2013-02-28 | Shire Human Genetic Therapies Inc. | Stabilizovane kompozicije glukocerebrozidaze |
| ES2294976B1 (es) * | 2007-11-12 | 2008-12-16 | Grifols, S.A. | "procedimiento de obtencion de albumina humana de alta eficacia para su uso en terapia de detoxificacion". |
| JP5990880B2 (ja) * | 2011-08-31 | 2016-09-14 | 東レ株式会社 | 有用タンパク質組成物およびその製造方法 |
| CN102816230B (zh) * | 2012-08-27 | 2014-02-12 | 同路生物制药股份有限公司 | 人血白蛋白的制备方法 |
| ES2524516B1 (es) * | 2014-05-29 | 2015-03-31 | Grifols Worldwide Operations Limited | Procedimiento de preparación de albúmina humana con nivel de oxígeno disuelto reducido |
-
2014
- 2014-05-29 ES ES201430824A patent/ES2524516B1/es not_active Expired - Fee Related
-
2015
- 2015-04-01 PL PL15382164T patent/PL2952203T3/pl unknown
- 2015-04-01 ES ES15382164.0T patent/ES2601137T3/es active Active
- 2015-04-01 PT PT153821640T patent/PT2952203T/pt unknown
- 2015-04-01 HU HUE15382164A patent/HUE031823T2/en unknown
- 2015-04-01 EP EP15382164.0A patent/EP2952203B9/en active Active
- 2015-05-01 CA CA2890642A patent/CA2890642C/en active Active
- 2015-05-06 AU AU2015202413A patent/AU2015202413B2/en active Active
- 2015-05-15 MY MYPI2015701570A patent/MY171771A/en unknown
- 2015-05-18 RU RU2015118453A patent/RU2657578C2/ru active
- 2015-05-19 IL IL238898A patent/IL238898B/en active IP Right Grant
- 2015-05-20 ZA ZA2015/03539A patent/ZA201503539B/en unknown
- 2015-05-21 MX MX2015006407A patent/MX362869B/es active IP Right Grant
- 2015-05-22 CN CN201510264800.9A patent/CN105315362B/zh active Active
- 2015-05-26 BR BR102015012091A patent/BR102015012091A8/pt not_active IP Right Cessation
- 2015-05-26 TW TW104116876A patent/TWI607018B/zh not_active IP Right Cessation
- 2015-05-26 SG SG10201504137PA patent/SG10201504137PA/en unknown
- 2015-05-27 AR ARP150101653A patent/AR100618A1/es active IP Right Grant
- 2015-05-27 NZ NZ708537A patent/NZ708537A/en not_active IP Right Cessation
- 2015-05-28 US US14/724,649 patent/US10350274B2/en active Active
- 2015-05-28 JP JP2015108569A patent/JP2015224251A/ja active Pending
- 2015-05-28 KR KR1020150074568A patent/KR101960729B1/ko active Active
- 2015-05-28 CL CL2015001446A patent/CL2015001446A1/es unknown
-
2018
- 2018-04-27 JP JP2018086673A patent/JP2018115210A/ja active Pending
-
2020
- 2020-04-20 JP JP2020074749A patent/JP2020111614A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2601137T3 (es) | Procedimiento de preparación de albúmina humana con nivel de oxígeno disuelto reducido | |
| MX2015000990A (es) | Analogos del glucagon. | |
| UY36766A (es) | Derivados de sulfamoilarilamida ciclados como inhibidores del vhb, procesos de preparación y composiciones farmacéuticas que los contienen | |
| MX2017002028A (es) | Compuestos de pirrolopirimidina usados como agonista del receptor de tipo toll 7 (tlr7). | |
| CL2017000984A1 (es) | Reducción de la viscosidad de formulaciones farmacéuticas | |
| CL2015002608A1 (es) | Compuesto de amino-pirazol y usos medicinales relacionados. | |
| DOP2016000253A (es) | Nuevos compuestos | |
| CY1120125T1 (el) | Διαδικασια για την παραγωγη ενος ενεσιμου διαλυματος νοραδρεναλινης σε σταθερη χαμηλη συγκεντρωση | |
| EA201791182A1 (ru) | Новые производные 2'- и/или 5'-аминокислотных эфиров фосфороамидатов 3'-дезоксиаденозина в качестве противораковых соединений | |
| BR112016022394A2 (pt) | Composição farmaceuticamente aceitável, composição na forma de uma solução injetável farmaceuticamente aceitável, uso da composição, e, método para a preparação da composição injetável farmaceuticamente aceitável | |
| BR112015030268A2 (pt) | composição farmacêutica, recipiente, kit, e, método para a preparação de uma composição | |
| MX2016011290A (es) | Composiciones de ester de colina de acido lipoico y metodos de uso. | |
| CO2017005968A2 (es) | Pirazolpiridinaminas como inhibidores de mknk1 y mknk2 | |
| EA201790726A1 (ru) | Фармацевтическая композиция для лечения язвенного колита | |
| CR20160235A (es) | Tienopirimidinas como inhibidores mknk1 y mknk2 | |
| CO2017003004A2 (es) | Nuevas triazolo[4,5-d]pirimidinas | |
| PE20150167A1 (es) | (r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel | |
| BR112016029012A2 (pt) | método de tratamento de câncer de pulmão de células não pequenas e/ou câncer de pulmão de células pequenas usando compostos de tienotriazolodiazepina | |
| UY36150A (es) | Derivados de naftiridinadiona | |
| BR112016015190A2 (pt) | Composição farmacêutica não contendo antioxidante e método de preparação da mesma | |
| BR112017002915A2 (pt) | processo para manufaturar um dispositivo de uso médico customizável e dispositivo obtido pelo dito processo | |
| DOP2016000251A (es) | Inhibidores de las vías de señalización de wnt | |
| CO2019003761A2 (es) | Derivados sustituidos de 6-(1h-pirazol-1-il)pirimidin-4-amina y usos de los mismos | |
| BR112017009850A2 (pt) | composto, composição, e, uso de uma quantidade melhoradora de hiv de um composto | |
| CO2017003313A2 (es) | Un proceso para la producción de complejos de caseína n-acetil-aspartilada de hierro (iii) y uso del mismo en com-posiciones farmacéuticas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |